✦ LIBER ✦
335 Interim results of a randomized trial of 1.5μG/ KG vs. 3.0 μG/KG pegylated interferon alfa 2-B PEG-intron(R) (PEG) plus ribavirin (RBV) for naïve chronic hepatitis C patients and 3.0μG/KG PEG plus RBV for non-responders (NR) and relapsers (R) to previous therapy. (The target trial)
✍ Scribed by Calvin L. White; Peter F. Malet; Corinne L. Wentworth; Veronica L. Cantu; Tamera L. Alton; William M. Lee
- Book ID
- 119530244
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 157 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.